Rich, a partner in Goodwin’s life sciences group, focuses her practice on general securities and corporate law with an emphasis on representing private and public companies in the health care industry. Among her recent clients is one that invented a pill for COVID-19.
She joined Goodwin in 2019 after working at the Silicon Valley offices of other firms, notably at Latham & Watkins LLP for mentor Alan C. Men...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In